Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
Information source: Stanford University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Fetal Distress
Intervention: nitroglycerin and terbutaline (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: Stanford University Official(s) and/or principal investigator(s):
Yasser Yehia El-Sayed, Principal Investigator, Affiliation: Stanford University
Summary
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
Clinical Details
Official title: Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation
Study design: Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment
Primary outcome: resolution of abnormal fetal heart tracing
Secondary outcome: cesarean section rateoperative vaginal delivery rate neonatal outcomes
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria::
- nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease,
placental abruption, intrauterine growth restriction, prior cesarean section
Locations and Contacts
Stanford University School of Medicine, Stanford, California 94305, United States
Additional Information
Last updated: May 7, 2008
|
